Medrisesp. z o.o.Active

Research and experimental development in natural sciences and engineering

KRS: 0001031993 NIP: 7123453760 REGON: 52509490200000

Overview

Registry date
2023-04-19
Share capital
$1,350.62
Activity description

Medrise is a clinical research center established in 2023 by a group of experienced physicians. The company conducts clinical trials for new drugs and therapies targeting various diseases, including ulcerative colitis and Crohn's disease.

Registered address
Ul. Onyksowa 10, 20-582 Lublin, Poland
Website
medrise.plWebsite active
Email
Email warning
Electronic delivery address
AE:PL-62269-64515-TBDFW-22

Accounts

Registered as a VAT taxpayer on 2023-11-01.Active

Authorized Representatives

Ownership

Change history

EventDetailsDate
PKD changeRemoved: 72.19.Z2026-03-23

FAQ

Last updated: 2026-04-07